Associated Papers
Biallelic variants of ATP13A3 cause dose-dependent childhood-onset pulmonary arterial hypertension characterised by extreme morbidity and mortality.
Machado RD et al.
Journal of Medical Genetics, 2022
Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension.
Eichstaedt CA et al.
Respiratory Research, 2022
Mutually reinforcing effects of genetic variants and interferon-β 1a therapy for pulmonary arterial hypertension development in multiple sclerosis patients.
Lerche M et al.
Pulmonary Circulation, 0
Select a paper to view details